Thank you for Subscribing to Food Business Review Weekly Brief
Thank you for Subscribing to Food Business Review Weekly Brief
By
Food Business Review | Sunday, July 03, 2022
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Consumers are often misled by misleading labeling, undisclosed substances, and the absence of rigorous testing, highlighting the need for improved regulation and safety measures in the nutraceutical industry.
FREMONT, CA: A category of items known as nutraceuticals include tablets, powders, bars, and tinctures containing components sourced from both plant and animal dietary sources. According to their producers, these supplements help prevent or treat diseases, including cancer and heart disease, enhance gastrointestinal health, and promote overall well-being. These goods, which fall between vitamins and processed foods (many nutraceuticals contain vitamins, but not all), are abundant in pharmacy aisles and online advertisements. According to market research, they were valued at over USD 400 billion globally.
However, a few products on this market could harm people's health and safety. The clinical testing and chemical verification of nutraceuticals in the United States are currently not properly regulated by any government agencies, and these products are frequently rife with quality and safety issues. Manufacturers of nutraceuticals are free to conduct their own safety and purity tests, but they are not obligated to report the results to the FDA or have them independently confirmed.
FDA clearance often takes years and involves multiple stages of research and testing, from fundamental effectiveness, where the treatment works as intended, to human safety, where trials involving tens of thousands of individuals to track adverse responses and side effects. The organization also conducts factory inspections and, in the event of a problem, can order the recall of a medicine. In addition to postmarket regulation, nutraceuticals lack these safeguards.
Consumers would believe these items to be reliable and secure. After all, many of them sit in pharmacies next to OTC medications. There is little doubt that this uncertainty benefits nutraceutical businesses. Additionally, customers might not carefully read the labels on nutraceuticals, which must state that the FDA has not reviewed any claims about the products and that they should not be used in place of recognized medical procedures. People may choose these items for critical conditions instead of medical procedures, or they may take one that combines with their present meds.
In the United States, according to CDC research, dietary supplement side effects are responsible for almost 2,000 hospitalizations, 23,000 emergency department visits, and around 23,000 visits overall. Several studies have implicated Prenatal vitamins as being tainted with heavy metals like lead. Because many of these items do not contain what the ingredient list claims or even report all of their contents, regulators frequently have no method of detecting the dangerous substances in these goods.